期刊文献+

Vsig4和免疫球蛋白Fc段融合蛋白的真核表达纯化 被引量:1

A Fusion Protein of Vsig4 and Immunoglobulin Fc Domain Expression and Purification via Mammalian System Expression
原文传递
导出
摘要 目的:本项目将通过构建中国仓鼠卵巢细胞(Chinese hamster ovary,CHO)真核表达系统获取小鼠Vsig4膜外端和免疫球蛋白Ig G3a-Fc段的融合蛋白,鉴定Vsig4-Fc和Vsig4纳米抗体的相互作用。方法:采用重合延伸PCR法融合小鼠Ig G3a-Fc和Vsig4胞外段的基因序列,将该融合基因插入真核表达载体中并转染CHO细胞。Western blotting鉴定转染细胞上清中的目标蛋白,通过连续两次亚克隆筛选,获得高表达小鼠Vsig4-Fc融合蛋白的单克隆,之后大量培养增殖转染细胞并收集细胞培养上清,选择Protein A柱纯化方法纯化Vsig4-Fc蛋白,最后经ELISA法鉴定Vsig4-Fc和纳米抗体的结合能力。结果:在CHO细胞中成功构建了小鼠Vsig4-Fc真核表达稳转系,并且在真核表达体系中获得可表达15 mg/L的双分子结构Vsig4-Fc的稳定转染细胞系。经鉴定小鼠Vsig4-Fc融合蛋白能与Vsig4纳米抗体结合。结论:重合延伸PCR法使得Vsig4和Fc基因片段的融合更为高效,两次亚克隆筛选优势细胞系大幅提高了真核蛋白的表达量,为进一步研究Vsig4的生物学功能奠定重要基础。 Objective: The current research aims to construct the extracellular domain of Vsig4 and the Fc domain of mouse immunoglobulin IgG3a fusion protein via mammalian expression system for Vsig4 functional assays. Methods: The gene of Fc region includes hinge-CH2-CH3 in mouse IgG3a. It was introduced to the C terminal of Vsig4 extracellular domain gene via overlapping extension PCR. Then, the chimeric plasmid was generated by inserting the fusion DNA fragment into pEGZ-Term/Vsig4-Fc plasmids. After transfection of CHO cells by chimeric plasmids using Lipofectamine, the CHO/Vsig4-Fc transfectants was selected by complete medium containing Geneticin. Furthermore, continuous cloning and medium ELISA were performed to gain higher yield of fusion protein. Protein A column was chosen for the fusion protein purification and expression of fusion protein were validated via ELISA using anti-Vsig4 nanobody. Results: The CHO transfectants which produce Vsig4-Fc fusion protein in yield of 15 mg/mL and with bivalent form were generated successfully. The Vsig4-Fc protein is able to bind with anti-Vsig4 Nanobody. Conclusions: The fusion DNA fragment of Vsig4 and Fc was generated by overlapping extension PCR method and the fusion protein was produced. The Vsig4 functional assays in the fields of T cells activity regulation and complement pathway inhibition will be benefited with the presented fimctional Vsig4-Fc fusion protein.
出处 《现代生物医学进展》 CAS 2016年第26期5001-5005,5134,共6页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81501527) 陕西省自然科学基础研究计划-青年人才项目(2016JQ3024) 西安交通大学基本科研业务费(xjj2015048)
关键词 Vsig4-Fc 融合蛋白 真核蛋白表达 蛋白质纯化 重合延伸PCR Vsig4-Fc Fusion protein Mammalian protein expression Purification Overlapping extension PCR
  • 相关文献

参考文献23

  • 1Jung K,Seo SK, Choi I. Endogenous VSIG4 negatively regulates thehelper T cell-mediated antibody response [J]. Immunol Lett, 2015,2(165): 78-83.
  • 2Vogt L, Schmitz N,Kurrer MO, et al. VSIG4, a B7 family-relatedprotein, is a negative regulator of T cell activation [J]. J Clin Invest,2006,10(116):2817-2826.
  • 3Liao Y,Guo S, Chen Y, et al. VSIG4 expression on macrophagesfacilitates lung cancer development [J]. Lab Invest, 2014,7 (94):706-715.
  • 4Xu T, Jiang Y, Yan Y, et al. VSIG4 is highly expressed and correlatedwith poor prognosis of high-grade glioma patients [J]. Am J TranslRes, 2015,6(7): 1172-1180.
  • 5He JQ, Katschke KJ Jr, Gribling P, et at. CRIg mediates early Kupfiercell responses to adenovirus[J]. J Leukoc Biol, 2013, 2(93): 301-306.
  • 6Kim KH, Choi BK, Song KM, et al. CRIg signals induce anti-intracellular bacterial phagosome activity in a chloride intracellularchannel 3-dependent manner [J], Eur J Immunol, 2013,3 (43):667-678.
  • 7Shiga Y, Oshima Y, Kojima Y,et al. Recombinant human lactoferrin-Fc fusion with an improved plasma half-life [J], Eur J Pharm Sci,2015,67: 136-143.
  • 8Qiao Q, Teng X,Wang N,et al. A novel CRIg-targeted complementinhibitor protects cells from complement damage [J]. FASEB J, 2014,11(28):4986-4999.
  • 9Zheng F, Put S, Bouwens L, et al. Molecular imaging with macrophageCRIg-targeting nanobodies for early and preclinical diagnosis in amouse model of rheumatoid arthritis [J]. J Nucl Med, 2014, 5(55):824-829.
  • 10Zheng F, Devoogdt N, Sparkes A, et al. Monitoring livermacrophages using nanobodies targeting Vsig4: concanavalin Ainduced acute hepatitis as paradigm [J]. Immunobiology, 2015, 2(220): 200-209.

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部